SLGL
SLGL
NASDAQ · Pharmaceuticals

Sol-Gel Technologies Ltd

$63.81
-1.88 (-2.86%)
As of Nov 7, 2:20 AM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target -80.6% upside
Low Target $7.31
Average Target $12.40
High Target $17.49
Current Price $63.81
Current
$63.81
Target
$12.40
$7.31 $12.40 avg $17.49
Scenario Analysis
Bear Case
$7.31
-88.5%
Low target
Base Case
$12.40
-80.6%
Avg target
Bull Case
$17.49
+-72.6%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$97.97
-34.9% from high
52-Week Low
$28.81
+121.5% from low
Target vs 52W High
$12.40
-87.3% vs high
Next Earnings Report
Nov 18, 2026
10d
until earnings
EPS Est: $-2.11
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%